Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.
about
Vaccines for preventing influenza in healthy adultsEffectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analysesThe relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adultsPrevention and treatment of influenza with hyperimmune bovine colostrum antibodyEfficacy and correlates of protection for cell culture-derived and egg-derived inactivated influenza vaccines in younger adults.Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartumAntibodies against conserved antigens provide opportunities for reform in influenza vaccine designSafety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine: results of a randomized trialPhase IV: randomized controlled trial to evaluate lot consistency of trivalent split influenza vaccines in healthy adultsIncidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis.CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adultsInfluenza vaccine immunogenicity in patients with primary central nervous system malignancy.Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adultsComparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysisAge-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individualsHemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza DiseaseStrategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice.Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease.Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains.CD4 T cell help is limiting and selective during the primary B cell response to influenza virus infection.Influvac, a trivalent inactivated subunit influenza vaccine.Assessing vaccine efficacy in influenza clinical trials: challenges and difficulties.Pilot investigation into the sickness response to influenza vaccination in adults: Effect of depression and anxiety.Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.Safety of a Trivalent Inactivated Influenza Vaccine in Health Care Workers in Kurdistan Province, Western Iran; A Longitudinal Follow-up Study.Recent advances in the production of recombinant subunit vaccines in Pichia pastoris.Increasing herd immunity with influenza revaccination.Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination.Log transformation: application and interpretation in biomedical research.The seasonal incidence of symptomatic influenza in the United States.A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination.No evidence for the immunocompetence handicap hypothesis in male humans.A Novel Representation of Vaccine Efficacy Trial Datasets for Use in Computer Simulation of Vaccination Policy.Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto ButantanThe Accuracy of Influenza DiagnosisEstimating Vaccine-Driven Selection in Seasonal InfluenzaReply: Cochrane rearranged
P2860
Q24197955-F467F4F6-DFA2-46AA-B8E2-4E48D453E811Q24614487-87A0CFAC-2B25-4CE8-8D1E-23C098F4AEB1Q24622008-24E8F5CC-31D7-459C-8030-7E3367BFE3C4Q28748705-20593095-E86C-45CF-9E01-683C17278243Q30226435-17AF49FF-8D58-4E12-9A12-D017FD81A056Q30399334-32B97B64-2A5D-4123-934B-5DDFE82EA3D1Q30413366-BE93A362-EF9B-4ACC-84A6-95C2E5A15DE1Q30416502-DECFEA20-0660-46DA-B481-0728CB06A1ADQ30429170-DAEBCF0C-A56B-4DFD-B58D-42CBE1C0F00CQ33723445-A8F38D27-CB26-4524-8B57-80A968FC1A8AQ34058480-64A7EB4E-7C34-4CD1-ABBE-2DFA9351FFEFQ34104346-ACDAE9F6-9532-40E5-8BD5-99C16C6BCCBFQ34511678-F764055B-A600-4887-9096-2731EA570012Q34729188-2933B92B-694B-4D7E-9016-D059BDF2A1B1Q34783486-9D893C87-1655-479A-8B5D-48B224CCB6D7Q35575511-0DAA25F8-99F6-4C59-94FA-CAD973B4B0E5Q35815281-DC22D259-C340-4262-AF93-99444C95DFCAQ35837747-D15A11F4-C939-4190-B79B-209DEFB7C17DQ35981831-0CEC2006-87C6-4D61-A407-4D928C1AAB91Q36385284-CA209978-FCF1-419D-98FF-E07F7AB109C2Q36854011-6802B55C-EB9F-4B09-B43B-087FADEB2F92Q37547668-FBD797BE-3384-4A6B-8398-77F6648E5C66Q37812615-B752068F-23A1-4BB5-AA21-EBBEDF631AF3Q38127468-BFBDF490-6EAC-4CD7-A3F7-6BBDB2A4CC0EQ38639288-4ABA6A98-DCF6-4E8C-94BB-6B2ABD43CA20Q38660898-3E2EB2E9-85F8-4445-8903-D42403D2B791Q38846084-CBB77A82-50C1-4211-A7EC-767504604706Q38849581-0959B936-7A42-4282-97F2-4C2FA6E8D8B6Q41201663-03933A8E-7216-4125-82E4-C5900334A7E0Q41921639-DD26A5D7-8A54-4D99-8C01-2D7B7197F9ABQ46104233-882BE37F-D696-41E3-8700-723351393B87Q47690334-C489A2B4-8044-4588-8654-4593458AFB15Q47843797-D6FD1439-F69B-4D31-9108-9EB85AE75EB9Q53091538-35F5E7C9-6A35-42C2-BBAE-73F05A1BADE4Q55033958-301569AD-EEEC-4ECA-BC0E-680C29638398Q55052340-075C67FF-32E8-411C-A7E1-6A58FB72779DQ56525461-48408E7C-18E8-47B5-9405-83BA5EEE37F0Q57279195-56724E52-0567-43E6-BB6A-8D86EBE3C454Q58722425-7F5FEDB3-3301-400C-A28D-EDEDF576FF52Q84819137-0896defd-43fb-4284-4943-a6bd1259bd1c
P2860
Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Safety, efficacy, and immunoge ...... al over two influenza seasons.
@ast
Safety, efficacy, and immunoge ...... al over two influenza seasons.
@en
Safety, efficacy, and immunoge ...... al over two influenza seasons.
@nl
type
label
Safety, efficacy, and immunoge ...... al over two influenza seasons.
@ast
Safety, efficacy, and immunoge ...... al over two influenza seasons.
@en
Safety, efficacy, and immunoge ...... al over two influenza seasons.
@nl
prefLabel
Safety, efficacy, and immunoge ...... al over two influenza seasons.
@ast
Safety, efficacy, and immunoge ...... al over two influenza seasons.
@en
Safety, efficacy, and immunoge ...... al over two influenza seasons.
@nl
P2093
P2860
P356
P1476
Safety, efficacy, and immunoge ...... al over two influenza seasons.
@en
P2093
John Balser
John J Treanor
Lisa A Jackson
Louis Fries
Manjusha J Gaglani
Nancy Bouveret
P2860
P2888
P356
10.1186/1471-2334-10-71
P577
2010-03-17T00:00:00Z
P5875
P6179
1047163670